| |
|
|
Zdravilo z dovoljenjem za promet |
- |
147708 |
|
|
|
Eli Lilly and Company (Ireland) Limited |
|
|
L04AC13 iksekizumab |
raztopina za injiciranje |
|
|
|
|
Zdravilo z dovoljenjem za promet |
- |
147710 |
|
|
|
Eli Lilly and Company (Ireland) Limited |
|
|
L04AC13 iksekizumab |
raztopina za injiciranje |
|
|
|
|
Zdravilo z dovoljenjem za promet |
- |
147709 |
|
|
|
Eli Lilly and Company (Ireland) Limited |
|
|
L04AC13 iksekizumab |
raztopina za injiciranje |
|
|
|
|
Zdravilo z dovoljenjem za promet |
- |
147713 |
|
|
|
Eli Lilly and Company (Ireland) Limited |
|
|
L04AC13 iksekizumab |
raztopina za injiciranje |
|
|
|
|
Zdravilo z dovoljenjem za promet |
- |
147712 |
|
|
|
Eli Lilly and Company (Ireland) Limited |
|
|
L04AC13 iksekizumab |
raztopina za injiciranje |
|
|
|
|
Zdravilo z dovoljenjem za promet |
- |
147711 |
|
|
|
Eli Lilly and Company (Ireland) Limited |
|
|
L04AC13 iksekizumab |
raztopina za injiciranje |
|
|